|
Index of reports
> Cases with Hepatic Function Abnormal (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) where reactions include hepatic function abnormal. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vfend side effects in male
Reported by a pharmacist from United States on 2012-07-18
Patient: male, weighing 11.3 kg (24.9 pounds)
Reactions: Hepatic Function Abnormal, Rash, Skin Reaction
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-24
Patient: 50 year old female, weighing 41.8 kg (92.0 pounds)
Reactions: Hepatic Function Abnormal, Abdominal Wall Haematoma, Renal Impairment, Diarrhoea, Constipation, Full Blood Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-09-08
End date: 2010-09-15
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2010-09-16
End date: 2010-09-25
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-10-12
End date: 2010-10-14
Vfend
Dosage: 400 milligram
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-09-01
Other drugs received by patient: Cotrim; Lansoprazole; Prednisolone; Morphine; Levothyroxine Sodium; Candesartan Cilexetil; Ozex; Urso 250; Polaramine; Fentanyl-100; Lendormin D; Gabapentin; Acetaminophen; Itraconazole; Restamin Cortisone; Prednisolone; Zometa; Fentanyl-100
Possible Vfend side effects in male
Reported by a physician from Japan on 2012-04-24
Patient: male
Reactions: Hepatic Function Abnormal, Cardiomyopathy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-02
Patient: male, weighing 51.0 kg (112.2 pounds)
Reactions: Hepatic Function Abnormal, Renal Impairment, Pancytopenia
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Ambisome
Dosage: 120 mg, uid/qd
Indication: Systemic Mycosis
Start date: 2010-11-17
End date: 2010-11-30
Ambisome
Dosage: 165 mg, uid/qd
Start date: 2010-12-01
End date: 2010-12-10
Ambisome
Dosage: 220 mg, uid/qd
Indication: Cranial Nerve Disorder
Start date: 2010-12-11
End date: 2011-04-08
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Indication: Cranial Nerve Disorder
Start date: 2011-01-13
End date: 2011-01-13
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-20
End date: 2011-01-20
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-17
End date: 2011-02-17
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-09
End date: 2011-02-09
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-03
End date: 2011-02-03
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Indication: Fungal Infection
Start date: 2011-01-06
End date: 2011-01-06
Funguard
Dosage: 150 mg, uid/qd
Indication: Fungal Rhinitis
Start date: 2010-12-18
End date: 2011-04-12
Funguard
Indication: Cranial Nerve Disorder
Funguard
Indication: Systemic Mycosis
Vfend
Dosage: 220 mg, bid
Indication: Cranial Nerve Disorder
Start date: 2011-01-11
End date: 2011-04-09
Vfend
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-04-10
End date: 2011-05-16
Vfend
Dosage: 300 mg, bid
Indication: Systemic Mycosis
Start date: 2010-11-17
End date: 2010-11-25
Vfend
Dosage: 200 mg, bid
Start date: 2010-12-02
End date: 2011-01-10
Vfend
Dosage: 300 mg, bid
Administration route: Oral
Start date: 2011-04-09
End date: 2011-04-09
Other drugs received by patient: Epinastine Hydrochloride; Metformin HCL; Hydrocortisone Sodium Succinate; Humalog; Actos; Lantus; Meropenem; Kinedak
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21
Patient: male, weighing 51.0 kg (112.2 pounds)
Reactions: Renal Impairment, Hepatic Function Abnormal, Pancytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Ambisome
Dosage: 120 mg, uid/qd
Start date: 2010-11-17
End date: 2010-11-30
Ambisome
Dosage: 220 mg, uid/qd
Indication: Systemic Mycosis
Start date: 2010-12-11
End date: 2011-04-08
Ambisome
Dosage: 165 mg, uid/qd
Start date: 2010-12-01
End date: 2010-12-10
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-20
End date: 2011-01-20
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-09
End date: 2011-02-09
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-06
End date: 2011-01-06
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-13
End date: 2011-01-13
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-03
End date: 2011-02-03
Fungizone
Dosage: 50 mg, uid/qd
Indication: Fungal Infection
Start date: 2011-02-17
End date: 2011-02-17
Funguard
Dosage: 150 mg, uid/qd
Indication: Fungal Rhinitis
Start date: 2010-12-18
End date: 2011-04-12
Vfend
Dosage: 300 mg, bid
Indication: Cranial Nerve Disorder
Start date: 2010-11-17
End date: 2010-11-25
Vfend
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-04-10
End date: 2011-05-16
Vfend
Dosage: 220 mg, bid
Indication: Systemic Mycosis
Start date: 2011-01-11
End date: 2011-04-09
Vfend
Dosage: 300 mg, bid
Administration route: Oral
Start date: 2011-04-09
End date: 2011-04-09
Vfend
Dosage: 200 mg, bid
Start date: 2010-12-02
End date: 2011-01-10
Other drugs received by patient: Lantus; Humalog; Hydrocortisone Sodium Succinate; Metformin HCL; Actos; Epinastine Hydrochloride; Meropenem; Kinedak
Possible Vfend side effects in 98 year old female
Reported by a physician from Japan on 2012-02-15
Patient: 98 year old female
Reactions: Hepatic Function Abnormal, Hyperammonaemia, Pulmonary Mycosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Ambisome
Dosage: 100 mg, 1x/day
Start date: 2011-09-03
End date: 2011-09-09
Ambisome
Dosage: 200 mg, 1x/day
Indication: Pulmonary Mycosis
Start date: 2011-09-02
End date: 2011-09-02
Meropenem
Dosage: 0.5 g, 2x/day
Indication: Lobar Pneumonia
Start date: 2011-08-26
End date: 2011-08-30
Meropenem
Dosage: 0.5 g, 2x/day
Start date: 2011-09-04
End date: 2011-09-08
Minocycline HCL
Dosage: 100 mg, 2x/day
Start date: 2011-09-05
End date: 2011-09-06
Minocycline HCL
Dosage: 200 mg, 1x/day
Start date: 2011-09-04
End date: 2011-09-04
Minocycline HCL
Dosage: 100 mg, 1x/day
Indication: Lobar Pneumonia
Start date: 2011-08-26
End date: 2011-08-30
Vfend
Dosage: 200 mg, 2x/day
Indication: Pulmonary Mycosis
Start date: 2011-09-04
End date: 2011-09-04
Vfend
Dosage: 200 mg, 1x/day
Start date: 2011-09-05
End date: 2011-09-08
Other drugs received by patient: Teicoplanin; Teicoplanin; Hanp; Buprenorphine HCL; Micafungin Sodium; Miraclid; Haloperidol; Fragmin; Teicoplanin; Teicoplanin; Omeprazole; Ciprofloxacin; Prodif; Elaspol
Possible Vfend side effects in 74 year old female
Reported by a pharmacist from Japan on 2012-02-06
Patient: 74 year old female
Reactions: Hepatic Function Abnormal, Shock Haemorrhagic, Tremor, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: 400 mg/day
Administration route: Oral
Start date: 2011-11-16
Vfend
Dosage: 400 mg/day
Indication: Systemic Candida
Start date: 2011-11-09
End date: 2011-11-15
Other drugs received by patient: Paxil; Ketas; Depakene; Depas
Possible Vfend side effects in 74 year old female
Reported by a physician from Japan on 2012-01-31
Patient: 74 year old female
Reactions: Hepatic Function Abnormal, Shock Haemorrhagic, Decreased Appetite, Tremor
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: 400 mg/day
Administration route: Oral
Start date: 2011-11-16
Vfend
Dosage: 400 mg/day
Indication: Systemic Candida
Start date: 2011-11-09
End date: 2011-11-15
Possible Vfend side effects in 98 year old female
Reported by a physician from Japan on 2012-01-23
Patient: 98 year old female
Reactions: Hepatic Function Abnormal, Hyperammonaemia, Pulmonary Mycosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Ambisome
Dosage: 200 mg, 1x/day
Indication: Pulmonary Mycosis
Start date: 2011-09-02
End date: 2011-09-02
Ambisome
Dosage: 100 mg, 1x/day
Start date: 2011-09-03
End date: 2011-09-09
Meropenem
Dosage: 0.5 g, 2x/day
Start date: 2011-09-04
End date: 2011-09-08
Meropenem
Dosage: 0.5 g, 2x/day
Indication: Lobar Pneumonia
Start date: 2011-08-26
End date: 2011-08-30
Minocycline HCL
Dosage: 100 mg, 2x/day
Start date: 2011-09-05
End date: 2011-09-06
Minocycline HCL
Dosage: 100 mg, 1x/day
Indication: Lobar Pneumonia
Start date: 2011-08-26
End date: 2011-08-30
Minocycline HCL
Dosage: 200 mg, 1x/day
Start date: 2011-09-04
End date: 2011-09-04
Vfend
Dosage: 200 mg, 2x/day
Indication: Pulmonary Mycosis
Start date: 2011-09-04
End date: 2011-09-04
Vfend
Dosage: 200 mg, 1x/day
Start date: 2011-09-05
End date: 2011-09-08
Other drugs received by patient: Prodif; Haloperidol; Buprenorphine HCL; Teicoplanin; Teicoplanin; Ciprofloxacin; Teicoplanin; Fragmin; Teicoplanin; Hanp; Micafungin Sodium; Omeprazole; Elaspol; Miraclid
Possible Vfend side effects in 61 year old male
Reported by a physician from Japan on 2012-01-17
Patient: 61 year old male
Reactions: Hepatic Function Abnormal, Renal Impairment, Visual Impairment, Paralysis, Pancytopenia
Drug(s) suspected as cause:
Amphotericin B
Indication: Sinusitis Fungal
Micafungin
Indication: Sinusitis Fungal
Vfend
Indication: Sinusitis Fungal
Possible Vfend side effects in 98 year old female
Reported by a physician from Japan on 2012-01-17
Patient: 98 year old female
Reactions: Hepatic Function Abnormal, Hyperammonaemia, Pulmonary Mycosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Ambisome
Dosage: 200 mg, 1x/day
Indication: Pulmonary Mycosis
Start date: 2011-09-02
End date: 2011-09-02
Ambisome
Dosage: 100 mg, 1x/day
Start date: 2011-09-03
End date: 2011-09-09
Meropenem
Dosage: 0.5 g, 2x/day
Indication: Lobar Pneumonia
Start date: 2011-08-26
End date: 2011-08-30
Meropenem
Dosage: 0.5 g, 2x/day
Start date: 2011-09-04
End date: 2011-09-08
Minocycline HCL
Dosage: 100 mg, 1x/day
Indication: Lobar Pneumonia
Start date: 2011-08-26
End date: 2011-08-30
Minocycline HCL
Dosage: 200 mg, 1x/day
Start date: 2011-09-04
End date: 2011-09-04
Minocycline HCL
Dosage: 100 mg, 2x/day
Start date: 2011-09-05
End date: 2011-09-06
Vfend
Dosage: 200 mg, 1x/day
Start date: 2011-09-05
End date: 2011-09-08
Vfend
Dosage: 200 mg, 2x/day
Indication: Pulmonary Mycosis
Start date: 2011-09-04
End date: 2011-09-04
Other drugs received by patient: Miraclid; Teicoplanin; Teicoplanin; Teicoplanin; Haloperidol; Fragmin; Micafungin Sodium; Hanp; Teicoplanin; Omeprazole; Prodif; Elaspol; Ciprofloxacin; Buprenorphine HCL
Possible Vfend side effects in 74 year old female
Reported by a pharmacist from Japan on 2011-12-14
Patient: 74 year old female
Reactions: Aneurysm Ruptured, Hepatic Function Abnormal, Tremor, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: 400 mg/day
Administration route: Oral
Start date: 2011-11-16
Vfend
Dosage: 400 mg/day
Indication: Systemic Candida
Start date: 2011-11-09
End date: 2011-11-15
Possible Vfend side effects in 89 year old male
Reported by a physician from Japan on 2011-11-04
Patient: 89 year old male, weighing 48.0 kg (105.6 pounds)
Reactions: Hepatic Function Abnormal, Pleural Effusion, Generalised Oedema
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2010-11-24
End date: 2010-12-13
Vfend
Dosage: 400 mg, 2x/day
Administration route: Oral
Indication: Sinusitis Fungal
Start date: 2010-11-23
End date: 2010-11-23
Other drugs received by patient: Adalat; Aldactone; Magnesium Oxide; Ambisome; Amlodipine; Amaryl; Pursennid; Lasix; Carvedilol; Sigmart; Primperan TAB; Olmesartan Medoxomil; Lipitor; Actos; Lendormin
Possible Vfend side effects in 98 year old female
Reported by a physician from Japan on 2011-10-24
Patient: 98 year old female
Reactions: Death, Hepatic Function Abnormal, Ammonia Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: 800 mg/day
Indication: Pulmonary Mycosis
Start date: 2011-09-04
End date: 2011-09-04
Vfend
Dosage: 400 mg/day
Start date: 2011-09-05
End date: 2011-09-08
Possible Vfend side effects in female
Reported by a pharmacist from Japan on 2011-10-04
Patient: female, weighing 56.4 kg (124.1 pounds)
Reactions: Renal Impairment, Hepatic Function Abnormal, Hepatic Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Levofloxacin
Dosage: 500 mg, 1x/day
Start date: 2011-08-28
End date: 2011-09-05
Vancomycin
Dosage: 750 mg, 2x/day
Start date: 2011-08-30
End date: 2011-09-02
Vancomycin
Dosage: 1000 mg, 2x/day
Start date: 2011-08-24
End date: 2011-08-29
Vfend
Dosage: 100 mg, 2x/day
Start date: 2011-08-29
End date: 2011-09-01
Vfend
Dosage: 300 mg, 2x/day
Start date: 2011-08-28
End date: 2011-08-28
Vfend
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2011-09-02
End date: 2011-09-07
Other drugs received by patient: Alprostadil; Omeprazole; Antithrombin III Human; Propofol; Immunoglobulin Human Normal; FOY; Heparin Sodium; Meropenem; Sandostatin; Antithrombin III Human; Heparin Sodium; Fentanyl
|
